Dr. Javier Kimura

Renal pathologist · Gustave Roussy · France (FR) · Nephrology

Tier 3STK-0106GoodOwner MSL ABDr. Anna Becker

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Glomerular disease
Disease interests: FSGS, IGAN
Scientific interests: Surrogate endpointseGFR slope
Engagement preference: In person
Advisory boards: 1
Publications: 13
Source system: Veeva CRM
Data quality: Good

Engagement plan

Cadence target for Tier 3: 1 per year (assumption)

Last engaged: 01 Jun 2026 (106 days ago)
Next planned contact: 01 Jun 2027
Last 6 months vs target: 100%
1 of 1 expected engagements

Insights from this stakeholder (1)

INS-0042Steroid-sparing strategies
01 Feb 2026 · Evidence gap
MediumClosed

Engagement history (3)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
01 Jun 2026	Scientific exchange	In person	Dr. Anna Becker	Nephrada	APRIL pathway mechanismeGFR slope interpretation+1	0	—	Reviewed	ENG-0137
08 Mar 2026	Investigator meeting	Virtual	Dr. Anna Becker	Nephrada	Proteinuria as surrogate endpointPatient-reported outcomes	0	—	Reviewed	ENG-0159
31 Jan 2026	Investigator meeting	Virtual	Dr. Anna Becker	Nephrada	Steroid-sparing strategies	1	—	Reviewed	ENG-0151

Timeline

01 Jun 2026
Scientific exchange
APRIL pathway mechanism, eGFR slope interpretation, Treatment burden and fatigue
08 Mar 2026
Investigator meeting
Proteinuria as surrogate endpoint, Patient-reported outcomes
31 Jan 2026
Investigator meeting
Steroid-sparing strategies

Related stakeholders (5)

Gustave Roussy

Dr. Hiroshi Zimmermann
Radiation oncologist
Tier 1
Dr. William Ivanova
Radiation oncologist
Tier 1
Dr. Chloé Xu
Oncology pharmacist
Tier 2
Dr. Ulrich Kimura
Oncology pharmacist
Tier 1
Dr. Yuki Castellano
Academic nephrologist
Tier 3